Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...

For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...

Using CRISPR co-culture screens, researchers found that deleting CHD1 and MAP3K7 makes tumor cells more vulnerable to immune ...

The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

A new publication from CorriXR Therapeutics, an oncology focused biotherapeutics company developing genetic medicines to ...

Advancements in genome editing technologies the growing emphasis on safe and accurate gene correction, and strong biotechnology R&D investment drive the base editing market.Austin, Texas, Jan. 21, ...

NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in vaso-occlusive crises for eligible patients.

The "Mice Model Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Mice Model ...

Humanized mouse models are essential for investigating human gene function; however, the complete replacement of mouse genes ...

ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the ...

Join the ELRIG conference to hear from experts on cell and gene therapy. Discover advancements shaping the future of medicine.

New one-dose treatment edits a gene in the liver, disabling the ANGPTL3 protein and significantly lowers cholesterol.